KM
HSTO

Kalos Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Kalos Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-220
Closed -$13K – 222
2020
Q1 		$13K Buy
220
+12
+6% +$937 0.01% 202
2019
Q4 		$16K Sell
208
-30
-13% -$2.1K 0.01% 203
2019
Q3 		$14K Hold
238
– – 0.01% 198
2019
Q2 		$12K Buy
+238
New +$41.3K 0.01% 193
2019
Q1 		– Sell
-255
Closed -$97K – 186
2018
Q4 		$97K Buy
255
+21
+9% +$16.3K 0.05% 181
2018
Q3 		$261K Buy
234
+159
+212% +$146K 0.14% 125
2018
Q2 		$82K Hold
75
– – 0.04% 195
2018
Q1 		$82K Buy
+75
New +$82.9K 0.05% 121

Other funds holding HSTO

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Kalos Management's HSTO Position: Q2 2020 in Review

Kalos Management sold out of Histogen Inc. Common Stock (HSTO) in Q2 2020, closing a stake of 220 shares — an estimated $13K sold.

Kalos Management first reported a position in HSTO in Q1 2018 and held it in 8 quarters. The position peaked at $261K in Q3 2018. 19 funds tracked by Wall St. Rank hold HSTO as of Q2 2020.

  • Kalos Management reported no remaining Histogen Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Kalos Management sold 220 Histogen Inc. Common Stock shares in Q2 2020, an estimated $13K.
  • Kalos Management first reported a position in Histogen Inc. Common Stock in Q1 2018 and held it in 8 quarters.
  • Kalos Management's Histogen Inc. Common Stock position peaked at $261K in Q3 2018.
  • 19 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2020.

Based on Kalos Management's 13F filing for Q2 2020, filed 13 Aug 2020.